Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-21-000247
Filing Date
2021-05-14
Accepted
2021-05-14 11:57:02
Documents
46
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 abti10q.htm 10-Q 234949
2 GRAPHIC image_001.gif GRAPHIC 5157
3 ex31_1.htm EX-31.1 8983
4 ex31_2.htm EX-31.2 9000
5 ex32_1.htm EX-32.1 5003
  Complete submission text file 0001663577-21-000247.txt   1416990

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE abti-20200630.xml EX-101.INS 140253
7 XBRL SCHEMA FILE abti-20200630.xsd EX-101.SCH 17701
8 XBRL CALCULATION FILE abti-20200630_cal.xml EX-101.CAL 25873
9 XBRL DEFINITION FILE abti-20200630_def.xml EX-101.DEF 42581
10 XBRL LABEL FILE abti-20200630_lab.xml EX-101.LAB 139692
11 XBRL PRESENTATION FILE abti-20200630_pre.xml EX-101.PRE 121510
Mailing Address 340 S. LEMON AVE., #4041 WALNUT CA 91789
Business Address 340 S. LEMON AVE., #4041 WALNUT CA 91789 909-584-5853
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-156091 | Film No.: 21922967
SIC: 1000 Metal Mining